MedPath

The interactive impact of psychological stress and malnutrition on genome stability and telomere integrity in Carers (Telomeres, stress and nutrition).

Not Applicable
Conditions
The molecular impact of psychological stress
DNA damage and telomere instability
Association of nutritional biomarkers with stress and DNA stability.
Diet and Nutrition - Other diet and nutrition disorders
Other - Research that is not of generic health relevance and not applicable to specific health categories listed above
Registration Number
ACTRN12613000524796
Lead Sponsor
Commonwealth Scientific and Industrial Research Organisation (CSIRO) Preventative Health Flagship
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Inclusion criteria - Carers: Primary carer of a person diagnosed with Alzheimer’s Disease (AD); =1 year since partner’s AD diagnosis; Male or female; Aged 65-90 years

Inclusion criteria - Control Group: Male or female; Aged 65-90 years.

Exclusion Criteria

Exclusion criteria - Carers: Diagnosed with a neurodegenerative condition, cognitive impairment or chronic illness requiring ongoing medical treatment; Undergoing chemotherapy/radiotherapy for cancer treatment; Supplementing with above RDI intakes of micronutrients associated with genome maintenance (eg. folate, vitamin B12); Consuming more than 3 standard alcoholic drinks/day; Smoker (5 or more cigarettes/day).

Exclusion criteria - Control Group: Carer for a family member with a serious chronic illness/condition, living in the home; Diagnosed with a neurodegenerative condition, cognitive impairment or chronic illness requiring ongoing medical treatment; Undergoing chemotherapy/radiotherapy for cancer treatment; Supplementing with above RDI intakes of micronutrients associated with genome maintenance (eg. folate, vitamin B12); Consuming more than 3 standard alcoholic drinks/day; Smoker (5 or more cigarettes/day).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Telomere length (TL) will be determined by flow cytometry, in primary leukocytes isolated from whole blood by gradient separation. TL will be measured in viable cells at G1 stage of the cell cycle.[Leukocytes will be isolated immediately upon blood collection, and viably frozen prior to TL measures being conducted.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath